Sort
51,593 grants matching “hepatitis”
Molecular Genetics Of Heritable Human Disorders
$1,545,705Janice Chou · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2019 · HD
University of Washington Interdisciplinary Center for Exposures, Diseases, Genomics & Environment
$1,545,000Terrance J Kavanagh · University Of Washington · P30 · FY2016 · ES
University of Washington Interdisciplinary Center for Exposures, Diseases, Genomics & Environment
$1,544,846Terrance J Kavanagh · University Of Washington · P30 · FY2017 · ES
Nonalcoholic Steatohepatitis: Natural History, Pathogenesis and Therapy
$1,544,379Yaron Rotman · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Addressing risk through Community Treatment for Infectious disease and Opioid use disorder Now (ACTION) among justice-involved populations
$1,544,013Sandra Ann Springer · Yale University · U01 · FY2020 · DA
MIAMI ADULT AIDS CLINICAL TRIALS GROUP, AACTG
$1,543,843University Of Miami School Of Medicine · U01 · FY2000 · AI
Johns Hopkins HIV Clinical Cohort
$1,543,732Richard Douglas Moore · Johns Hopkins University · U01 · FY2024 · DA
ADULT AIDS CLINICAL TRIALS UNIT
$1,543,278Duke University · U01 · FY2004 · AI
Functional Genomics Laboratory (FGL)
$1,542,975Anton Simeonov · National Center For Advancing Translational Sciences · ZIC · FY2023 · TR
ADULT AIDS CLINICAL TRIALS UNIT (ACTU)
$1,542,920University Of Southern California · U01 · FY2002 · AI
1/2 Sickel Cell Disease Treatment with Arginine Therapy (STArT Trial)
$1,542,812Claudia R Morris · Emory University · UH3 · FY2021 · HL
Ancillary Studies of NAFLD and NASH in HIV infected Adults
$1,542,615Naga P. Chalasani · Indiana University Indianapolis · R01 · FY2023 · DK
Experimental Therapeutics of Anti-Cancer Agents with Phase I Emphasis
$1,541,209William E. Carson · Ohio State University · UM1 · FY2019 · CA
MIAMI ADULT AIDS CLINICAL TRIALS GROUP, AACTG
$1,540,981University Of Miami School Of Medicine · U01 · FY2001 · AI
Qualification of Patient-Derived Biomimetic Liver MPS as Drug Discovery Tools for Drug Metabolism, Toxicity, Drug Efficacy Testing and Clinical Trial Cohort Selection
$1,540,258Mark E Schurdak · University Of Pittsburgh At Pittsburgh · U2C · FY2025 · TR
MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE)
$1,539,723Pamina Mae Gorbach · University Of California Los Angeles · U01 · FY2016 · DA
COLUMBIA-ADARC AIDS CLINICAL TRIALS UNIT
$1,537,934Columbia University Health Sciences · U01 · FY2001 · AI
Integrated Care Clinics for IDUs in India: a cluster randomized trial
$1,537,931Gregory M Lucas · Johns Hopkins University · R01 · FY2014 · DA
1/2 Sickel Cell Disease Treatment with Arginine Therapy (STArT Trial)
$1,537,648Claudia R Morris · Emory University · UG3 · FY2020 · HL
Studies of Rare Cancers
$1,537,322Louise Brinton · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA
The National Drug Abuse Treatment Clinical Trials Network
$1,537,275Walter Nmn Ling · University Of California Los Angeles · U10 · FY2013 · DA
The Center for Innovation in Point-of-Care Technologies for HIV/AIDS at Northwestern University (C-THAN)
$1,536,895Robert L. Murphy · Northwestern University · U54 · FY2021 · EB
PATHOBIOLOGY AND GENE TRANSFER IN CARDIOVASCULAR DISEASE
$1,536,624Lawrence Chan · Baylor College Of Medicine · P01 · FY2006 · HL
Mechanisms Of Drug-induced Toxicities
$1,536,028Lance R Pohl · National Heart, Lung, And Blood Institute · Z01 · FY2008 · HL
COLUMBIA-ADARC-CORNELL AIDS CLINICAL TRIALS UNIT
$1,535,019Columbia University Health Sciences · U01 · FY2003 · AI